Organon & Co. (NYSE:OGN) Downgraded by The Goldman Sachs Group to Neutral
The Goldman Sachs Group lowered shares of Organon & Co. (NYSE:OGN – Free Report) from a buy rating to a neutral rating in a report published on Friday, MarketBeat.com reports. The Goldman Sachs Group currently has $16.00 target price on the stock, down from their previous target price of $33.00. Other research analysts also recently […]
More Stories
Analyzing Mercury General (NYSE:MCY) & Deep Yellow (OTCMKTS:DYLLF)
Volatility & Risk Mercury General has a beta of 0.87, indicating that its stock price is 13% less volatile than...
Analyzing Mercury General (NYSE:MCY) & Deep Yellow (OTCMKTS:DYLLF)
Volatility & Risk Mercury General has a beta of 0.87, indicating that its stock price is 13% less volatile than...
Y-mAbs Therapeutics (NASDAQ:YMAB) Earns “Outperform” Rating from Wedbush
Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a research...
Y-mAbs Therapeutics (NASDAQ:YMAB) Earns “Outperform” Rating from Wedbush
Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a research...
VR Resources (CVE:VRR) Trading Down 16.7% – Here’s What Happened
VR Resources Ltd. (CVE:VRR – Get Free Report)’s share price traded down 16.7% during trading on Friday . The company...
VR Resources (CVE:VRR) Trading Down 16.7% – Here’s What Happened
VR Resources Ltd. (CVE:VRR – Get Free Report)’s share price traded down 16.7% during trading on Friday . The company...